OR WAIT null SECS
Making the Grade: The Importance of Using the Correct Excipient Grade in Drug Products
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
Activation and expansion are essential for success in both autologous and allogeneic therapies.
There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
This article explores the emergence of subjectivity in ICH Q9 (R1).
The Biosimilars Landscape
March 07, 2024
Sean Knight, Simtra BioPharma Solutions, reacts to the company's global expansion efforts and investment in sterile fill/finish.
Cellares CEO Fabian Gerlinghaus shares how an automated, closed-production platform with a small footprint can dramatically impact cost savings and scalability for cell and gene therapies.
March 06, 2024
Under a global license and collaboration agreement, AbbVie and OSE Immunotherapeutics will aim to develop OSE-230, a mAb for treating chronic inflammation.
The company is expanding GMP capacities at its Frankfurt site to manufacture early clinical-phase peptide APIs.
March 05, 2024
March 04, 2024
Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
CPHI North America is a three-day event offering opportunities to learn, innovate, and network in the pharmaceutical industry.
Excipient World is a US event focused exclusively on excipients.
The 6th Treg-Directed Therapies Summit will feature leading industry and academic experts in the Treg therapy field.